BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Drug Development

  Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a Booster

  Novavax, Inc. today announced topline results from its Phase 3 Boosting Trial for the SARS-CoV-2 rS Variant Vaccines (COVID-19) showing that the Company’s BA.1 vaccine candidate (NVX-CoV2515) met the primary strain-change endpoint.

  November 8, 2022

   · 

  9 min read
• Drug Development

  OnQuality Pharmaceuticals Annouces the Enrollment of the First Patient in Part 2 of the NOVA-II Phase 2 Clinical Trial

  OnQuality Pharmaceuticals today announced the enrollment of the first patient in Part 2 of the NOVA-II Phase 2 clinical trial.

  November 8, 2022

   · 

  3 min read
• Business

  Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

  Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology company, today provided a corporate update and reported financial results for the third quarter of 2022.

  November 8, 2022

   · 

  8 min read
• Genetown

  Apnimed to Present at the Stifel Healthcare Conference

  Apnimed today announced that management will participate in the Stifel Healthcare Conference taking place November 15-16, 2022 in New York.

  November 8, 2022

   · 

  3 min read
• Biotech Beach

  Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting

  Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that it will present two posters at the SFN 2022 Neuroscience Annual Meeting, taking place November 12-16, 2022, in San Diego, CA.

  November 8, 2022

   · 

  1 min read
• Genetown

  Scholar Rock to Participate in Upcoming Investor Conferences

  Scholar Rock today announced that management will participate in the following upcoming investor conferences.

  November 8, 2022

   · 

  2 min read
• BioMidwest

  AtriCure to Present at 34th Annual Piper Sandler Healthcare Conference

  AtriCure, Inc. today announced that the company will present at the 34th Annual Piper Sandler Healthcare Conference.

  November 8, 2022

   · 

  1 min read
• Drug Development

  SimBioSys, Inc. Awarded $2M Phase II NCI SBIR Contract to Support the Development of Its Multi-Scale Platform for Spatial Tumor Visualization and Analysis

  SimBioSys ® , the precision medicine company behind TumorScope®, the 4D tumor modeling platform for treatment planning, announced today it has been awarded a $2M Phase II Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI), part of the National Institutes of Health.

  November 8, 2022

   · 

  3 min read
• Genetown

  Vaxxas Announces Initiation of Phase I Clinical Study of First Needle-Free COVID-19 Vaccine (HexaPro) Delivered Using High-Density Microarray Patch (HD-MAP)

  Vaxxas holds an exclusive license from The University of Texas at Austin (UTA) to the SARS-CoV-2 spike subunit vaccine (HexaPro) for vaccination using a patch.

  November 8, 2022

   · 

  8 min read
• Business

  NeoDynamics hires National Sales Director for the launch of its NeoNavia® Biopsy System

  NeoDynamics AB (Nasdaq First North Growth Market Stockholm: NEOD.ST), a medical device company dedicated to advancing the diagnosis and care of cancer, today announced it hired Brendan Carney as National Sales Director.

  November 8, 2022

   · 

  1 min read